Shehaj, I.; Schröder, M.; Linz, V.C.; Krajnak, S.; Almstedt, K.; Stewen, K.; Schwab, R.; Hasenburg, A.; Schmidt, M.; Heimes, A.-S.
Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers. Cancers 2024, 16, 1371.
https://doi.org/10.3390/cancers16071371
AMA Style
Shehaj I, Schröder M, Linz VC, Krajnak S, Almstedt K, Stewen K, Schwab R, Hasenburg A, Schmidt M, Heimes A-S.
Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers. Cancers. 2024; 16(7):1371.
https://doi.org/10.3390/cancers16071371
Chicago/Turabian Style
Shehaj, Ina, Maria Schröder, Valerie Catherine Linz, Slavomir Krajnak, Katrin Almstedt, Kathrin Stewen, Roxana Schwab, Annette Hasenburg, Marcus Schmidt, and Anne-Sophie Heimes.
2024. "Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers" Cancers 16, no. 7: 1371.
https://doi.org/10.3390/cancers16071371
APA Style
Shehaj, I., Schröder, M., Linz, V. C., Krajnak, S., Almstedt, K., Stewen, K., Schwab, R., Hasenburg, A., Schmidt, M., & Heimes, A.-S.
(2024). Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers. Cancers, 16(7), 1371.
https://doi.org/10.3390/cancers16071371
